KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash from Discontinued Operations (2016 - 2021)

Historic Cash from Discontinued Operations for Tenet Healthcare (THC) over the last 13 years, with Q4 2021 value amounting to $1.0 million.

  • Tenet Healthcare's Cash from Discontinued Operations changed N/A to $1.0 million in Q4 2021 from the same period last year, while for Dec 2023 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of -$1.0 million for FY2022, which is N/A changed from last year.
  • As of Q4 2021, Tenet Healthcare's Cash from Discontinued Operations stood at $1.0 million.
  • Tenet Healthcare's Cash from Discontinued Operations' 5-year high stood at $2.0 million during Q1 2017, with a 5-year trough of -$4.0 million in Q2 2017.
  • Moreover, its 5-year median value for Cash from Discontinued Operations was -$1.0 million (2017), whereas its average is -$1.1 million.
  • Its Cash from Discontinued Operations has fluctuated over the past 5 years, first tumbled by 23333.33% in 2017, then soared by 20000.0% in 2019.
  • Quarter analysis of 5 years shows Tenet Healthcare's Cash from Discontinued Operations stood at -$2.0 million in 2017, then skyrocketed by 50.0% to -$1.0 million in 2018, then changed by 0.0% to -$1.0 million in 2019, then changed by 0.0% to -$1.0 million in 2020, then surged by 200.0% to $1.0 million in 2021.
  • Its Cash from Discontinued Operations was $1.0 million in Q4 2021, compared to -$1.0 million in Q3 2020 and -$1.0 million in Q4 2019.